We are live on !
Find out more
Jim Simons Renaissance Technologies
AUM
$72.6B
Turnover
31.08%
1-Year Est. Return
54.88%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.92%
AUM
$69.4B
AUM Growth
-$5.97B
(-7.9%)
Cap. Flow
-$8.1B
Cap. Flow % of AUM
Cap. Flow %
-11.68%
Top 10 Holdings %
Top 10 Hldgs %
11.91%
Holding
4,468
New
542
Increased
1,600
Reduced
1,691
Closed
597
Avg Time Held
2.8
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.33% |
| 2 | Healthcare | 16.97% |
| 3 | Consumer Discretionary | 12.83% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Novo Nordisk
NVO
$176B
| $1.52B | 2.19% |
18,741,976
-2,862,600
| -13% | -$234M |
2013 Q2
40 quarters
|
|
|
2
Meta Platforms (Facebook)
META
$1.6T
| $1.3B | 1.87% |
4,532,030
+2,623,447
| +137% | +$647M |
2021 Q3
7 quarters
|
|
|
3
Apple
AAPL
$5.03T
| $955M | 1.38% |
4,921,796
+4,912,234
| +51,372% | +$856M |
2020 Q3
11 quarters
|
|
|
4
NVIDIA
NVDA
$4.95T
| $785M | 1.13% |
18,559,040
+18,527,120
| +58,042% | +$615M |
2023 Q1
1 quarter
|
|
5
VeriSign
VRSN
$27.5B
| $691M | 1% |
3,056,590
-126,500
| -4% | -$27.9M |
2013 Q2
40 quarters
|
|
6
Airbnb
ABNB
$96.9B
| $679M | 0.98% |
5,294,527
-760,029
| -13% | -$88.9M |
2021 Q2
8 quarters
|
|
7
Palantir
PLTR
$442B
| $610M | 0.88% |
39,799,157
-814,600
| -2% | -$9.26M |
2021 Q2
8 quarters
|
|
8
Gilead Sciences
GILD
$212B
| $600M | 0.86% |
7,781,416
-2,802,800
| -26% | -$224M |
2014 Q4
34 quarters
|
|
9
Hershey
HSY
$33.3B
| $573M | 0.83% |
2,295,767
-7,600
| -0.3% | -$1.99M |
2013 Q2
40 quarters
|
|
10
Fortinet
FTNT
$100B
| $552M | 0.8% |
7,306,045
+1,075,400
| +17% | +$73.1M |
2015 Q3
31 quarters
|
|
|
11
Tesla
TSLA
$1.58T
| $548M | 0.79% |
2,091,807
-1,933,244
| -48% | -$387M |
2018 Q4
18 quarters
|
|
12
Franco-Nevada
FNV
$43.3B
| $499M | 0.72% |
3,500,703
+27,200
| +0.8% | +$4.08M |
2014 Q1
37 quarters
|
|
13
United Therapeutics
UTHR
$25.7B
| $483M | 0.7% |
2,187,214
-40,200
| -2% | -$8.9M |
2013 Q2
40 quarters
|
|
14
Boeing
BA
$136B
| $467M | 0.67% |
2,209,700
-382,400
| -15% | -$79.4M |
2022 Q4
2 quarters
|
|
15
Uber
UBER
$133B
| $449M | 0.65% |
10,390,900
+5,767,500
| +125% | +$214M |
2021 Q2
8 quarters
|
|
16
Vertex Pharmaceuticals
VRTX
$142B
| $448M | 0.65% |
1,272,161
-125,574
| -9% | -$42.3M |
2017 Q1
25 quarters
|
|
17
CrowdStrike
CRWD
$256B
| $420M | 0.61% |
11,445,316
+283,716
| +3% | +$9.9M |
2020 Q1
13 quarters
|
|
18
Kroger
KR
$39.4B
| $395M | 0.57% |
8,399,754
-1,629,100
| -16% | -$77.7M |
2019 Q2
16 quarters
|
|
19
Snowflake
SNOW
$108B
| $387M | 0.56% |
2,198,699
-223,900
| -9% | -$36.4M |
2022 Q1
5 quarters
|
|
20
Zoom
ZM
$27.9B
| $372M | 0.54% |
5,486,068
-1,087,347
| -17% | -$72.7M |
2020 Q1
13 quarters
|
|
21
Atlassian
TEAM
$48.5B
| $369M | 0.53% |
2,201,223
+468,300
| +27% | +$75M |
2016 Q2
28 quarters
|
|
|
HZNP
22
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $355M | 0.51% |
3,448,749
+80,300
| +2% | +$8.47M |
2017 Q2
24 quarters
|
|
23
Caterpillar
CAT
$286B
| $330M | 0.48% |
1,340,010
-148,790
| -10% | -$33.2M |
2022 Q4
2 quarters
|
|
24
lululemon athletica
LULU
$12.4B
| $329M | 0.47% |
868,800
+103,400
| +14% | +$38.2M |
2023 Q1
1 quarter
|
|
25
Chipotle Mexican Grill
CMG
$40.3B
| $328M | 0.47% |
7,670,000
+7,355,000
| +2,335% | +$291M |
2022 Q2
4 quarters
|
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 597 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 542 new positions and closed 597 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.